Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials
Titel:
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials
Auteur:
Choderlos de Laclos, Xavier Risbourg, Séverine Brennan, Bernadette Bertucci, François Gaspar, Nathalie Gelderblom, Hans Hawkins, Douglas S. Janeway, Katherine Juergens, Heribert Kasper, Bernd Krailo, Mark D. Cécile Le Deley, Marie Marec-Bérard, Perrine McCabe, Martin G. Metzler, Markus Ranft, Andreas Strauss, Sandra Tabone, Marie-Dominique Windsor, Rachael Dirksen, Uta Gandemer, Virginie